Skip to content
DataLookout
Menu

SMART-BCNCT07924046

Diagnostic Performance of Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Bladder Tumour for Prediction of Muscle Invasion and Detection of Residual Tumour in Non-muscle-invasive Bladder Cancer Patients

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Diagnostic Performance
Timeframe: Approximately 3-4 weeks after initial transurethral resection, before repeat resection when clinically indicated.

Arms and interventions

Multiparametric Magnetic Resonance ImagingExperimental

Participants with suspected bladder cancer will undergo multiparametric magnetic resonance imaging before transurethral resection of bladder tumour. Patients requiring repeat resection according to clinical indications will undergo a second magnetic resonance imaging examination approximately 3-4 weeks after the initial resection. Imaging findings will be compared with histopathological results to assess diagnostic performance.

Diagnostic tests: Multiparametric Magnetic Resonance Imaging of the Bladder